Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Moretti

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 15, 2010
Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysisElena Galfrascoli, Sheila Piva, Michela Cinquini, et al.
Tumori|September 12, 2015
A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local projectNicla La Verde, Fabio Corsi, Anna Moretti, et al.
Plos One|December 7, 2017
The prognostic role of tumor size in early breast cancer in the era of molecular biologyAnaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, et al.
Plos One|April 12, 2013
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patientsMarina Chiara Garassino, Sheila Piva, Nicla La Verde, et al.
Tumori|December 24, 2013
Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centersNicla La Verde, Elena Collovà, Sara Lonardi, et al.
Clinical Breast Cancer|December 21, 2020
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO StudyNicla La Verde, Elena Collovà, Livio Blasi, et al.
Plos One|August 8, 2019
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE studySerena Di Cosimo, Nicla La Verde, Anna Moretti, et al.
Future Oncology (London, England)|December 4, 2013
Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom controlNicla La Verde, Anna Moretti, Gabriella Farina, et al.
Breast Cancer Research : BCR|October 29, 2022
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER studyNicla La Verde, Giovanna Damia, Ornella Garrone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 15, 2010
Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysisElena Galfrascoli, Sheila Piva, Michela Cinquini, et al.
Tumori|September 12, 2015
A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local projectNicla La Verde, Fabio Corsi, Anna Moretti, et al.
Plos One|December 7, 2017
The prognostic role of tumor size in early breast cancer in the era of molecular biologyAnaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, et al.
Plos One|April 12, 2013
Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patientsMarina Chiara Garassino, Sheila Piva, Nicla La Verde, et al.
Tumori|December 24, 2013
Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centersNicla La Verde, Elena Collovà, Sara Lonardi, et al.
Clinical Breast Cancer|December 21, 2020
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO StudyNicla La Verde, Elena Collovà, Livio Blasi, et al.
Plos One|August 8, 2019
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE studySerena Di Cosimo, Nicla La Verde, Anna Moretti, et al.
Future Oncology (London, England)|December 4, 2013
Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom controlNicla La Verde, Anna Moretti, Gabriella Farina, et al.
Breast Cancer Research : BCR|October 29, 2022
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER studyNicla La Verde, Giovanna Damia, Ornella Garrone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Pageof 2